Prevalence and associated factors of worry for cancer in patients with a Barrett’s esophagus

• Published in: Scientific reports Vol. 14; no. 1; p. 2878
• Main Authors: van der Ende-van Loon, M. C. M., Oude Nijhuis, R. A. B., Curvers, W. L., Schoon, E. J.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 04.02.2024; Nature Publishing Group; Nature Portfolio
• Subjects: 631/67; 692/1807/1808; 692/4020; Adenocarcinoma - pathology; Barrett Esophagus - complications; Barrett Esophagus - epidemiology; Barrett's esophagus; Cross-Sectional Studies; Esophageal cancer; Esophageal carcinoma; Esophageal Neoplasms - pathology; Female; Gastroesophageal Reflux - complications; Gastroesophageal Reflux - epidemiology; Genetics; Health risks; Humanities and Social Sciences; Humans; Male; multidisciplinary; Patients; Prevalence; Questionnaires; Science; Science (multidisciplinary); Statistical analysis
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-024-53428-y

Although the risk of cancer progression in a Barrett’s esophagus (BE) is very low, worrying about cancer is known as an important factor affecting HRQoL. The aim of this study was to determine the proportion of BE patients with high levels of worry for cancer, to compare outcomes of patients endoscopically treated for BE neoplasia (DBE), non-dysplastic BE patients (NDBE) and patients with reflux symptoms, and to examine associated factors. We performed a cross sectional, exploratory, self-administered questionnaire study using the cancer worry scale, and the reflux disease questionnaire. A total of 192 DBE patients, 213 NDBE patients and 111 refractory reflux symptom patients were included from October 2019 until July 2021, 76.8% of BE participants were male and aged 66.9 years. High cancer worry was reported in 40.6% of the DBE patients and 36.2% of NDBE patient. Reflux patients scored statistically significant worse with 56.6% stated high cancer worry. Positive correlations were found between reflux symptoms and cancer worry in NDBE patients and reflux patients. In DBE patients’ negative correlations were found between higher cancer worry and younger age as well as a family history of esophageal carcinoma. A clinically significant group of BE patients reported high cancer worry, which was associated with reflux symptoms in NDBE patients and a younger age and a (family) history of esophageal carcinoma diagnosis in BE patients treated for (early) neoplasia. Physicians should communicate about the actual cancer risk, which leads to greater patient understanding and therefore may have a positive impact on health outcomes.